Table 2 The top 16 O. volvulus targets and their predicted drugs.

From: The genome of Onchocerca volvulus, agent of river blindness

Ov gene ID

Function of family

Drugs (WHO name)

ATC level 3 classification

OVOC2713

Ribonucleotide reductase, small chain

Fludarabine phosphate, clofarabine, gemcitabine, (hydroxyurea), gallium nitrate

Antimetabolites, other antineoplastic agents.

OVOC11146

Calcineurin-like phosphoesterase

Tiagabine

Antiepileptics

OVOC215

Sodium neurotransmitter symporter family

Imipramine, clomipramine, amitriptyline, nortriptyline, protriptyline, amoxapine, fluoxetine, citalopram, paroxetine, sertraline, fluvoxamine, escitalopram, trazodone, nefazodone, venlafaxine, milnacipran, duloxetine, desvenlafaxine, vilazodone, vortioxetine, (levomilnacipran, chlorphentermine)

Antidepressants (unclassified)

OVOC3747

Ion transport protein

Dronedarone, (nimodipine, felodipine)

Antiarrhythmics, class I and III (selective calcium channel blockers with mainly vascular effects)

OVOC1986

KQT-1 potassium channel

Dronedarone

Antiarrhythmics, class I and III

OVOC1111

Receptor family ligand binding region

Baclofen, oxybate

Muscle relaxants, central acting agents, null

OVOC5191

G-protein coupled GABA receptor activity

  

OVOC12632 OVOC12637 OVOC12635 OVOC968

NADH-ubiquinone oxidoreductase chains 1, 4 and 5; probable NADH dehydrogenase [ubiquinone] iron-sulfur protein 7

Metformin

Blood glucose lowering drugs excluding insulin

OVOC6309

3-oxo-5-α-steroid 4-dehydrogenase

Dutasteride

Drugs used in benign prostatic hypertrophy

OVOC10592

ERG2 and sigma1 receptor like protein

Pentazocine, (dextromethorphan)

Opiods, cough suppressants (other nervous system drugs)

OVOC8585

C-terminal tandem repeated domain in type 4 procollagen

Xiaflex, (ocriplasmin)

Other drugs for disorders of the musculoskeletal system (other ophthalmologicals)

OVOC10695

Glycosyl transferase family 21

Miglustat, eliglustat

Other alimentary tract and metabolism products

OVOC4110

Amidase

Acetaminophen

Other analgesics and antipyretics

  1. The table shows anatomical therapeutic classification groups for drugs identified as potential repurposing candidates. For drugs in parentheses, the mechanism is shown in similar style parentheses in the ‘ATC level 3 classification’ column.